Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Beyond mortality: future clinical research in acute lung injury.

Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, Hall J, Israel E, Jain M, Needham DM, Randolph AG, Rubenfeld GD, Schoenfeld D, Thompson BT, Ware LB, Young D, Harabin AL.

Am J Respir Crit Care Med. 2010 May 15;181(10):1121-7. doi: 10.1164/rccm.201001-0024WS.

2.

Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.

Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA; NHLBI ARDS Clinical Trials Network..

Chest. 2010 Feb;137(2):288-96. doi: 10.1378/chest.09-1484.

3.

Recent trends in acute lung injury mortality: 1996-2005.

Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD; NIH NHLBI ARDS Network..

Crit Care Med. 2009 May;37(5):1574-9. doi: 10.1097/CCM.0b013e31819fefdf.

4.

Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.

Calfee CS, Eisner MD, Parsons PE, Thompson BT, Conner ER Jr, Matthay MA, Ware LB; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network..

Intensive Care Med. 2009 Feb;35(2):248-57. doi: 10.1007/s00134-008-1235-0. Review.

5.

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.

Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA; NHLBI ARDS Network..

Thorax. 2008 Dec;63(12):1083-9. doi: 10.1136/thx.2008.095588.

6.

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J.

N Engl J Med. 2008 May 15;358(20):2107-16. doi: 10.1056/NEJMoa0707064.

7.

Predictors of hospital mortality in a population-based cohort of patients with acute lung injury.

Cooke CR, Kahn JM, Caldwell E, Okamoto VN, Heckbert SR, Hudson LD, Rubenfeld GD.

Crit Care Med. 2008 May;36(5):1412-20. doi: 10.1097/CCM.0b013e318170a375.

PMID:
18434894
8.

Variation in ICU risk-adjusted mortality: impact of methods of assessment and potential confounders.

Kuzniewicz MW, Vasilevskis EE, Lane R, Dean ML, Trivedi NG, Rennie DJ, Clay T, Kotler PL, Dudley RA.

Chest. 2008 Jun;133(6):1319-27. doi: 10.1378/chest.07-3061.

PMID:
18403657
9.

Technology Insight: biomarker development in acute kidney injury--what can we anticipate?

Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J.

Nat Clin Pract Nephrol. 2008 Mar;4(3):154-65. doi: 10.1038/ncpneph0723. Review.

PMID:
18227821
10.

Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome.

Bajwa EK, Boyce PD, Januzzi JL, Gong MN, Thompson BT, Christiani DC.

Crit Care Med. 2007 Nov;35(11):2484-90.

PMID:
18084839
11.

Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders.

Calfee CS, Eisner MD, Ware LB, Thompson BT, Parsons PE, Wheeler AP, Korpak A, Matthay MA; Acute Respiratory Distress Syndrome Network, National Heart, Lung, and Blood Institute..

Crit Care Med. 2007 Oct;35(10):2243-50.

12.

Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.

Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network..

Crit Care Med. 2007 Aug;35(8):1821-8.

13.

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS.

Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12.

PMID:
17569110
14.

Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.

Karmpaliotis D, Kirtane AJ, Ruisi CP, Polonsky T, Malhotra A, Talmor D, Kosmidou I, Jarolim P, de Lemos JA, Sabatine MS, Gibson CM, Morrow D.

Chest. 2007 Apr;131(4):964-71.

15.
16.

Multiple biomarkers for the prediction of first major cardiovascular events and death.

Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS.

N Engl J Med. 2006 Dec 21;355(25):2631-9.

17.

Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury.

McClintock DE, Ware LB, Eisner MD, Wickersham N, Thompson BT, Matthay MA; National Heart, Lung, and Blood Institute ARDS Network..

Am J Respir Crit Care Med. 2007 Feb 1;175(3):256-62.

18.

Higher urine desmosine levels are associated with mortality in patients with acute lung injury.

McClintock DE, Starcher B, Eisner MD, Thompson BT, Hayden DL, Church GD, Matthay MA; National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network..

Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L566-71.

19.

Incidence and outcomes of acute lung injury.

Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD.

N Engl J Med. 2005 Oct 20;353(16):1685-93.

20.
Items per page

Supplemental Content

Support Center